a clinical-stage biopharmaceutical company, which focuses on the development and commercialization of innovative therapies for nonalcoholic steatohepatitis (NASH), liver and cardio-metabolic diseases
Industry Biotechnology
A.I.dvisor indicates that over the last year, ETNB has been loosely correlated with AKRO. These tickers have moved in lockstep 63% of the time. This A.I.-generated data suggests there is some statistical probability that if ETNB jumps, then AKRO could also see price increases.
Ticker / NAME | Correlation To ETNB | 1D Price Change % | ||
---|---|---|---|---|
ETNB | 100% | +1.01% | ||
AKRO - ETNB | 63% Loosely correlated | +4.72% | ||
PLRX - ETNB | 49% Loosely correlated | +4.74% | ||
NTLA - ETNB | 46% Loosely correlated | -1.87% | ||
IDYA - ETNB | 46% Loosely correlated | +1.07% | ||
ALLO - ETNB | 45% Loosely correlated | +0.49% | ||
More |